Form D · Biotechnology
Human Biotech, Inc.
Cambridge, MA · CIK 0002126389
Offering snapshot reported Jun 3, 2026 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 22, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 3, 2026 | Initial | $9,999,997 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-586044
Source: Form D, filed Jun 3, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Errik B. Anderson | Director |
| Andrew Danielsen | Director |
| Agustin Javier Lopez Marquez | Director, Executive, Promoter |
| Dusan Perovic | Director |
| Ankit Saxena | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
77 New Street Unit 420
Cambridge, MA, 02138
Cambridge, MA, 02138